PTCT — PTC Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $3.39bn
- $4.76bn
- $937.82m
- 41
- 35
- 96
- 57
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 687 | 1,104 | 773 | 411 | 877 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 55.5 | 69.9 | 110 | 156 | 161 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 779 | 1,232 | 954 | 694 | 1,219 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 35.2 | 118 | 130 | 175 | 179 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 1,624 | 2,208 | 1,938 | 1,706 | 1,896 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 236 | 277 | 509 | 406 | 603 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,029 | 1,726 | 1,937 | 2,053 | 2,714 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 594 | 482 | 1.44 | -347 | -819 |
Total Liabilities & Shareholders' Equity | 1,624 | 2,208 | 1,938 | 1,706 | 1,896 |
Total Common Shares Outstanding |